mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.2 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.2 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.2 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.2 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |